3-(n-acetyl-n-hydroxy)aminopropylphosphonic acid has been researched along with Disease Models, Animal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bacher, A; Behrendt, C; Brücher, K; Fischer, M; Gräwert, T; Held, J; Illarionov, B; Konzuch, S; Kurz, T; Lienau, C; Maes, L; Mordmüller, B; Wittlin, S | 1 |
Altincicek, B; Beck, E; Dreiseidler, E; Jomaa, H; Reichenberg, A; Sanderbrand, S; Schlitzer, M; Weidemeyer, C; Wiesner, J | 1 |
2 other study(ies) available for 3-(n-acetyl-n-hydroxy)aminopropylphosphonic acid and Disease Models, Animal
Article | Year |
---|---|
Prodrugs of reverse fosmidomycin analogues.
Topics: Animals; Antimalarials; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Fosfomycin; HeLa Cells; Humans; Malaria; Mice; Mice, SCID; Molecular Structure; Plasmodium berghei; Plasmodium falciparum; Prodrugs; Structure-Activity Relationship | 2015 |
Diaryl ester prodrugs of FR900098 with improved in vivo antimalarial activity.
Topics: Aldose-Ketose Isomerases; Animals; Antimalarials; Disease Models, Animal; Fosfomycin; Malaria; Mice; Multienzyme Complexes; Organophosphonates; Oxidoreductases; Plasmodium; Prodrugs; Treatment Outcome | 2001 |